Announcements Trials
Browse Landscape

Phase

Phase NA 21Phase 4 3Phase 3 3Phase 2 3Phase 1 1

Status

Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 276Neoplasms 202Prostatic Neoplasms 118Polycystic Ovary Syndrome 114Colorectal Neoplasms 103Carcinoma, Hepatocellular 103Carcinoma, Non-Small-Cell Lung 88Lung Neoplasms 70Stomach Neoplasms 62Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Pain 59Neoplasm Metastasis 54Multiple Myeloma 52Pancreatic Neoplasms 46Keratosis, Actinic 46Head and Neck Neoplasms 43Pain, Postoperative 42Leukemia, Myeloid, Acute 40Leiomyoma 39Recurrence 38Liver Neoplasms 38Colonic Neoplasms 37Uterine Cervical Neoplasms 35Lymphoma 35Brain Neoplasms 34Infertility 33Papillomavirus Infections 32Ovarian Neoplasms 31Lymphoma, Follicular 31Lymphoma, Non-Hodgkin 30

Interventions

Indocyanine Green 1Dry Needling 1Bupivacaine 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Neuroma × Clear all
NCT06164392 2025-01-01

Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography

Northwestern University

Phase 4 Withdrawn

Neuroma

NCT04460521 2024-08-23

ACTS

Nova Scotia Health Authority

Phase 4 Recruiting
240 enrolled

Tomaculous neuropathy, Carpal Tunnel Syndrome, Disease, Hand Injuries, Neuroma, Median Neuropathy

NCT01632709 2015-07-21

PPAP

Shirley Ryan AbilityLab

Phase 4 Completed
16 enrolled 12 charts

Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡